NEW YORK, July 3 – Three out of four of the largest mergers and acquisitions that occurred in the pharmaceutical sector in the second quarter involved genomics companies, and the consolidation trend is expected to continue, said Steven Burrill, CEO of Burrill & Company, a San Francisco-based merchant bank.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.

A new paper critiques the analysis and conclusions of the Atacama mummy genome sequencing study.

In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.

An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.